Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 13, 2009
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression
Christian Wider, Justus C Dachsel, Alexandra I Soto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 17, 2004
Levodopa in the treatment of Parkinson's disease: current controversies
C Warren Olanow, Yves Agid, Yoshi Mizuno, et al.
Nature Genetics
|
June 9, 2016
Identification of TMEM230 mutations in familial Parkinson's disease
Han-Xiang Deng, Yong Shi, Yi Yang, et al.
American Journal of Human Genetics
|
July 19, 2011
VPS35 mutations in Parkinson disease
Carles Vilariño-Güell, Christian Wider, Owen A Ross, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 31, 2024
A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinase
Emil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
The Lancet. Neurology
|
April 13, 2024
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
Emil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
Human Molecular Genetics
|
November 13, 2013
DNAJC13 mutations in Parkinson disease
Carles Vilariño-Güell, Alex Rajput, Austen J Milnerwood, et al.
Brain : a Journal of Neurology
|
November 1, 2016
Genome-wide association study in essential tremor identifies three new loci
Stefanie H Müller, Simon L Girard, Franziska Hopfner, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 13, 2009
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression
Christian Wider, Justus C Dachsel, Alexandra I Soto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 17, 2004
Levodopa in the treatment of Parkinson's disease: current controversies
C Warren Olanow, Yves Agid, Yoshi Mizuno, et al.
Nature Genetics
|
June 9, 2016
Identification of TMEM230 mutations in familial Parkinson's disease
Han-Xiang Deng, Yong Shi, Yi Yang, et al.
American Journal of Human Genetics
|
July 19, 2011
VPS35 mutations in Parkinson disease
Carles Vilariño-Güell, Christian Wider, Owen A Ross, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 31, 2024
A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinase
Emil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
The Lancet. Neurology
|
April 13, 2024
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
Emil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
Human Molecular Genetics
|
November 13, 2013
DNAJC13 mutations in Parkinson disease
Carles Vilariño-Güell, Alex Rajput, Austen J Milnerwood, et al.
Brain : a Journal of Neurology
|
November 1, 2016
Genome-wide association study in essential tremor identifies three new loci
Stefanie H Müller, Simon L Girard, Franziska Hopfner, et al.
Page
of 8